COMMUNIQUÉS West-GlobeNewswire

Assure Holdings Acquires Littleton Professional Reading
30/05/2019
- Accretive Acquisition Strengthens Assure’s Footprint in Colorado - DENVER, May 30, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative [...]
Progenics Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
30/05/2019
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
TRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
30/05/2019
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
30/05/2019
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases, [...]
Catalyst Pharmaceuticals Announces Expansion of Firdapse License to Include Japan
30/05/2019
CORAL GABLES, Fla., May 30, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Selecta Biosciences to Present at the Jefferies Healthcare Conference on June 06, 2019
30/05/2019
WATERTOWN, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its [...]
Fibrocell to Present at BIO International Convention 2019
30/05/2019
EXTON, Pa., May 30, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Mersana Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference
30/05/2019
CAMBRIDGE, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Allena Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
30/05/2019
NEWTON, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
LogicBio to Present at the Jefferies 2019 Healthcare Conference
30/05/2019
CAMBRIDGE, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced that Fred Chereau, [...]
Evelo Biosciences to Present at Upcoming Investor Conferences in June
30/05/2019
CAMBRIDGE, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing oral biologics that act on cells in the small intestine with [...]
Passage Bio Announces Third Gene Therapy Development Program in Krabbe Disease and Supports Million Dreams Fundraising Gala
30/05/2019
PHILADELPHIA, May 30, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that [...]
scPharmaceuticals Inc. to Present at Upcoming Investor Conferences
30/05/2019
BURLINGTON, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
Replimune to Present at Upcoming Investor Conferences
30/05/2019
WOBURN, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that members [...]
Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
30/05/2019
BOSTON, May 30, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Intra-Cellular Therapies to Present at Jefferies 2019 Global Healthcare Conference
30/05/2019
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced [...]
Neos Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference
30/05/2019
DALLAS and FORT WORTH, Texas, May 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting
30/05/2019
EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Immuron Announces the Closing of Public Offering of ADSs
30/05/2019
MELBOURNE, Australia, May 30, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the [...]

Pages